Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes
2012 StandoutScienceNobel
Formylglycine-generating enzyme binds substrate directly at a mononuclear Cu(I) center to initiate O 2 activation
2019 StandoutNobel
Directed Evolution Mimics Allosteric Activation by Stepwise Tuning of the Conformational Ensemble
2018 StandoutNobel
Morphological profiling of tubercle bacilli identifies drug pathways of action
2020
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
2014
Functional diversity of helper T lymphocytes
1996 StandoutNature
Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
2016
ICOS co-stimulatory receptor is essential for T-cell activation and function
2001 StandoutNatureNobel
Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation
2007
Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule
1995
Innate Immunity: The Virtues of a Nonclonal System of Recognition
1997 Standout
Regulation of αβ/γδ T Cell Lineage Commitment and Peripheral T Cell Responses by Notch/RBP-J Signaling
2004 StandoutNobel
A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
2000 Standout
Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
1993 Standout
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
2012
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
CD28 activation promotes Th2 subset differentiation by human CD4+ cells
1995
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients
2006
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
2005
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
1997 StandoutNobel
A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase
2017
Positional Specificity of Rabbit CYP4B1 for ω-Hydroxylation1of Short-Medium Chain Fatty Acids and Hydrocarbons
1998
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Helper T Cell Differentiation Is Controlled by the Cell Cycle
1998
Malignant Gliomas in Adults
2008 Standout
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
2014
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
2015
Complex reactions catalyzed by cytochrome P450 enzymes
2006
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
2013 Standout
Perforin: structure and function
1995
Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells
2004 StandoutNobel
B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological Synapse
2004 StandoutNobel
Cell-mediated cytotoxicity: contact and secreted factors
1993
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
2020 StandoutNobel
The Complexities of T‐Cell Co‐stimulation: CD28 and Beyond
1996
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4 + T Cells
1997 StandoutNobel
Thymocyte development is normal in CTLA-4-deficient mice
1997 StandoutNobel
Human Endothelial Cells Induce and Regulate Cytolytic T Cell Differentiation
1998
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4+T cell responses
1999 StandoutNobel
Repression of B7.2 on Self-reactive B Cells Is Essential to Prevent Proliferation and Allow Fas-mediated Deletion by CD4+ T Cells
1998 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
2003 StandoutNobel
Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3
2006 StandoutNobel
Tissue-Specific Inducible Expression of Antimicrobial Peptide Genes in Drosophila Surface Epithelia
2000 StandoutNobel
State of the Art and Prospects in Metal–Organic Framework (MOF)-Based and MOF-Derived Nanocatalysis
2019 Standout
Stat6 Regulation of In Vivo IL-4 Responses
2000
C−H Activation for the Construction of C−B Bonds
2009 Standout
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
2000 StandoutNobel
CD28/B7 SYSTEM OF T CELL COSTIMULATION
1996 Standout
ON IMMUNOLOGICAL MEMORY
1996
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
1995
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme
2005
Translational control of interleukin 2 messenger RNA as a molecular mechanism of T cell anergy.
1996
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
1997
Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction
2003 StandoutNobel
Pyrazinecarboxylic acid and analogs: Highly efficient co-catalysts in the metal-complex-catalyzed oxidation of organic compounds
2012
Natural products of filamentous fungi: enzymes, genes, and their regulation
2006
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
1999 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
1995
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+T cells
2000 StandoutNobel
Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
1999
Formation of Cyclopropanone during Cytochrome P450-Catalyzed N-Dealkylation of a Cyclopropylamine
2002
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Regio- and Enantioselective Alkane Hydroxylation with Engineered Cytochromes P450 BM-3
2003 StandoutNobel
Fatty acid‐specific, regiospecific, and stereospecific hydroxylation by cytochrome P450 (CYP152B1) from Sphingomonas paucimobilis: Substrate structure required for α‐hydroxylation
2000
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Fluorescent Mycobacterium tuberculosis reporters: illuminating host–pathogen interactions
2018
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
1996 StandoutScience
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation
1999 StandoutScience
Works of Ping Lü being referenced
Fatty acid discrimination and ω-hydroxylation by cytochrome P450 4A1 and a cytochrome P4504A1/NADPH-P450 reductase fusion protein
1995
MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
2003
CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
2004
Heteroatom Substitution Shifts Regioselectivity of Lauric Acid Metabolism from ω-Hydroxylation to (ω-1)-Oxidation
1995
Efficient disruption of a polyketide synthase gene (pks1) required for melanin synthesis through Agrobacterium-mediated transformation of Glarea lozoyensis
2003
Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences
2011
Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity
2009
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
2014
Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
2017
CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite.
1994
Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells
1992
Pyrazinoic Acid Decreases the Proton Motive Force, Respiratory ATP Synthesis Activity, and Cellular ATP Levels
2011
Bioactivation of 2,3-Diaminopyridine-Containing Bradykinin B1 Receptor Antagonists: Irreversible Binding to Liver Microsomal Proteins and Formation of Glutathione Conjugates
2005